Zacks Investment Research downgraded shares of CynergisTek (NYSEAMERICAN:CTEK) from a hold rating to a sell rating in a research report report published on Wednesday.

According to Zacks, “AUXILIO, Inc. provides Managed Print Services (MPS) for the health care industry. The Company provides management and monitoring of vital business and clinical processes in copy, print, fax and scan infrastructures. It operates as a vendor independent company and offers monitoring, management, and contract negotiation; change management and end-user training programs; utilization management; financial reporting; workflow efficiency management; information systems integration, connectivity, and image migration strategies; and strategy execution working with the customer to execute a long-term image management strategy. The Company sells and services automated office equipment, including digital and color copiers, printers, facsimile machines, scanners, and multi-function equipment. AUXILIO, Inc. is headquartered in Mission Viejo, California. “

CynergisTek (NYSEAMERICAN CTEK) opened at $3.75 on Wednesday. CynergisTek has a fifty-two week low of $2.36 and a fifty-two week high of $6.72.

ILLEGAL ACTIVITY WARNING: This news story was first posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/zacks-investment-research-lowers-cynergistek-ctek-to-sell/1767042.html.

About CynergisTek

Cynergistek, Inc provides outsourced document management services and IT security consulting services primarily to the healthcare industry in the United States. It offers workflow solutions; and creates manageable, dependable print management programs by managing the back-office processes of hospital clients.

Get a free copy of the Zacks research report on CynergisTek (CTEK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with MarketBeat.com's FREE daily email newsletter.